Journal of Clinical Virology
Volume 45, Issue 3 , Pages vii-ix , July 2009

Viral myocarditis

  • Davies E.

      Affiliations

    • West of Scotland Specialist Virology Centre, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN
    • ,
  • Ainsworth R.J.

      Affiliations

    • Department of Forensic Medicine and Science, University of Glasgow, G12 8QQ
    • ,
  • Aitken C.

      Affiliations

    • West of Scotland Specialist Virology Centre, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN
    • ,
  • Carman W.F.

      Affiliations

    • West of Scotland Specialist Virology Centre, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN
    • ,
  • Kroes A.C.M.

      Affiliations

    • Department of Medical Microbiology, Leiden University Medical Centre, Leiden, Netherlands

Received 3 June 2009 ,Accepted 3 June 2009.

References 

  1. Letouze N, Jokic M, Maragnes P, et al. Fulminant influenza type A associated myocarditis: a fatal case in an 8 year old child. Arch Mal Coeur Vaiss. 2006;99(5):514–516
  2. Agnino A, Schena S, Ferlan G, De Luca T, Schinosa L. Left ventricular pseudoaneurysm after acute influenza A myocardiopericarditis. J Cardiovasc Surg. 2002;43(2):203–205
  3. McGovern PC, Chambers S, Blumberg EA, et al. Successful explantation of a ventricular assist device following fulminant influenza type A-associated myocarditis. J Heart Lung Transplant. 2002;21(2):290–293
  4. Miura M, Asaumi Y, Wada Y, et al. A case of influenza subtype A virus-induced fulminant myocarditis: an experience of percutaneous cardio-pulmonary support (PCPS) treatment and immunohistochemical analysis. TohokuJ Exp Med. 2001;195(1):11–19
  5. Nolte KB, Alakija P, Oty G, et al. Influenza A virus infection complicated by fatal myocarditis. Am J Forensic Med Pathol. 2000;21(4):375–379
  6. Piancastelli M, Grilli M, Ravaioli ML, Preziosi S, Bellanti G, Zabberoni W. Acute viral myocarditis with transient concentric pseudohypertrophy of the left ventricle complicated by cardiogenic shock. G Ital Cardiol. 1993;23(12):1223–1228
  7. Franzen D, Mertens T, Waidner T, Kruppenbacher J, Hopp HW, Hilger HH. Perimyocarditis in influenza a virus infection. Klin Wochenschr. 1991;69(9):404–408
  8. Schmaltz AA, Seitz KH, Schenck W, Both WA, Kraus B. Restrictive cardiomyopathy as a late sequel of influenza a2 virus myocarditis. Z Kardiol. 1986;75(10):605–608
  9. Proby CM, Hackett D, Gupta S, Cox TM. Acute myopericarditis in influenza A infection. QJ Med. 1986;60(233):887–892
  10. Engblom E, Ekfors TO, Meurman OH, Toivanen A, Nikoskelainen J. Fatal influenza A myocarditis with isolation of virus from the myocardium. Acta Med Scand. 1983;213(1):75–78
  11. Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, et al. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation. 2005;1117:879–886
  12. SchenkT , Enders M, Pollak S, Hahn R, Huzly D. High Prevalence of Human Parvovirus B19 DNA in Myocardial Autopsy Samples from Subjects without Myocarditis or Dilative Cardiomyopathy. J. Clin. Microbiol. 2009;47:106–110
  13. Onitsuka H, Imamura T, Miyamoto N, Shibata Y, Kashiwagi T, Ayabe T, et al. Clinical manifestations of influenza a myocarditis during the influenza epidemic of winter 1998–1999. J Cardiol. 2001 Jun;37(6):315–323
  14. Mamas MA, Nair S, Fraser D. Cardiac tamponade and heart failure as a presentation of influenza. Exp Clin Cardiol. Winter. 2007;12(4):214–216

PII: S1386-6532(09)00270-4

doi: 10.1016/S1386-6532(09)00270-4

Journal of Clinical Virology
Volume 45, Issue 3 , Pages vii-ix , July 2009

Article Tools